Biogen | BIIB - Ebit

Cena Akcji
189.52
Dzienna Zmiana
0.39 0.21%
Miesięcznie
7.92%
Rocznie
61.69%
Q2 Prognozy TE
183.17




Ebit Zmiana Data
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
ALKERMES USD -48.28M 37.33M 2026-03
Amgen USD 3.83B 130M 2026-03
Bayer EUR 1.11B 1.51B 2025-12
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Merck USD -1.88B 8.12B 2026-03
Moderna USD -1.39B 531M 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 3.74B 2.23B 2025-09
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03